The 3 analysts offering 12-month price forecasts for Gracell Biotechnologies Inc have a median target of 33.00, with a high estimate of 40.00 and a low estimate of 27.00. The median estimate represents a +643.24% increase from the last price of 4.44.
The current consensus among 3 polled investment analysts is to Buy stock in Gracell Biotechnologies Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.16
Reporting Date Mar 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.